Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. (Q47826573)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 July 2013

Language	Label	Description	Also known as
English	Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.	scientific article published on 19 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

0 references

Plasmodium berghei

0 references

cerebral malaria

0 references

Bernhard Ryffel

13

object named as

Bernhard Ryffel

1 reference

Europe PubMed Central

5 February 2018

Jean-François Franetich

8

object named as

Jean-François Franetich

1 reference

Europe PubMed Central

5 February 2018

Dieudonnée Togbe

10

object named as

Dieudonnée Togbe

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

author name string

Jennifer Palomo

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Mathilde Fauconnier

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Laurie Coquard

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Maïlys Gilles

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Sandra Meme

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Frederic Szeremeta

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Lizette Fick

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Muazzam Jacobs

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Jean-Claude Beloeil

11

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Dominique Mazier

12

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Valerie F J Quesniaux

14

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

language of work or name

0 references

publication date

19 July 2013

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

European Journal of Immunology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

43

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

2683-2695

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

Pathogenesis, clinical features, and neurological outcome of cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

The role of animal models for research on severe malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Pathogenic T cells in cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Immunological processes in malaria pathogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Protein kinase C-theta is required for development of experimental cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Engagement of protein kinase C-theta in interferon signaling in T-cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Beta interferon suppresses the development of experimental cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

The role of platelets in the pathogenesis of cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Magnetic resonance imaging of the brain in patients with cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Respiratory Manifestations of Malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

VEGF promotes malaria-associated acute lung injury in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

IL-12Rβ2 is essential for the development of experimental cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

21 January 2018

Immunomodulatory functions of type I interferons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343327

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201343327

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23780878

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47826573&oldid=1744627919"